Results 1 to 10 of about 35,480 (291)

Effect of photobiomodulation therapy on painful temporomandibular disorders

Scientific Reports, 2021
To evaluate the effect of photobiomodulation therapy (PBMT) on painful temporomandibular disorders (TMD) patients in a randomized, double-blinded, placebo-controlled manner.
Adila Aisaiti, Yanli Zhou, Yue Wen, Weina Zhou, Chen Wang, Jing Zhao, Linfeng Yu, Jinglu Zhang, Kelun Wang, Peter Svensson   +9 more
doaj   +1 more source

Comparison of painful temporomandibular disorders, psychological characteristics, sleep quality, and oral health-related quality of life of patients seeking care before and during the Covid-19 pandemic

BMC Oral Health, 2023
Background Literature concerning Temporomandibular disorders (TMDs) and the Covid-19 pandemic is limited and disparate findings related to TMD frequencies, psychological distress, and quality of life were presented. This study investigated the prevalence
Adrian Ujin Yap, Jie Lei, Chengge Liu, Kai-Yuan Fu   +3 more
doaj   +1 more source

Parkinson’s disease, temporomandibular disorder pain and bruxism and its clinical consequences: a protocol of a single-centre observational outpatient study

BMJ Open, 2022
Introduction A recent questionnaire-based study suggested that bruxism and painful temporomandibular disorders (TMD pain) may be more prevalent in patients with Parkinson’s disease (PD) compared with controls.
Henk W Berendse, Karin D van Dijk, Merel Charlotte Verhoeff, Michail Koutris, F Lobbezoo   +4 more
doaj   +1 more source

Differences in Botulinum Toxin Injection Into Temporal Muscles in Sleep Bruxism and Chronic Migraine [PDF]

Sleep Medicine Research, 2022
Botulinum toxin (BoNT), a potent neurotoxin that reversibly blocks presynaptic acetylcholine release, has been used successfully to treat sleep bruxism (SB) and chronic migraine (CM). However, studies investigating injection protocols such as drug dosage
Jung Eun Lee, Bok Eum Kim, Seong Taek Kim   +2 more
doaj   +1 more source

Effect of Botulinum Toxin on Masticatory Muscle Pain in Patients with Temporomandibular Disorders: A Randomized, Double-Blind, Placebo-Controlled Pilot Study

Toxins, 2023
This study aimed to evaluate the efficacy of botulinum toxin type A (BoNT/A) in patients with temporomandibular disorders (TMDs) associated with masticatory muscle pain (MMP) and headaches. This randomized, double-blind, placebo-controlled pilot study is
So Ra Kim, Min Chang, Alec Hyung Kim, Seong Taek Kim   +3 more
doaj   +1 more source

Botulinum Toxin Injection for Managing Sleep Bruxism [PDF]

Sleep Medicine Research, 2018
Botulinum toxin (BoNT), a potent neurotoxin that reversibly blocks presynaptic acetylcholine release, has been applied successfully to treat severe sleep bruxism (SB).
Seurin Kim, Keun jeong Park, Young joo Shim, Seong Taek Kim   +3 more
doaj   +1 more source

Gabapentinoid prescription in Oral Medicine and Oral Surgery practice. Part II − a systematic scoping review of the literature

Journal of Oral Medicine and Oral Surgery, 2020
Introduction: Gabapentinoids, pregabalin and gabapentin, neuronal voltage-gated calcium channel inhibitors are first-line treatments for painful neuropathic conditions (and several non-neuropathic painful conditions).
Sulukdjian Arek, L'Homme Richard, Chanlon Audrey, Moreau Nathan   +3 more
doaj   +1 more source

Gabapentinoid prescription in oral medicine and oral surgery practice. Part I − Experience from a French Orofacial pain clinic

Journal of Oral Medicine and Oral Surgery, 2020
Gabapentinoids, pregabalin and gabapentin, are neuronal voltage-gated calcium channel inhibitors mainly prescribed for the treatment of partial epilepsy and neuropathic pain.
Sulukdjian Arek, L'homme Richard, Chanlon Audrey, Moreau Nathan   +3 more
doaj   +1 more source

Clinical Application of Inferior Alveolar Nerve Block Device for Safe and Secure IANB by Any Operator

Pain Research and Management, 2023
The inferior alveolar nerve block (IANB) is an established technique with a success rate of 60–80%; however, large errors have been reported among operators. Some dentists do not prefer to use IANB because of the risk of complications.
Tomoyasu Noguchi, Kento Odaka, Ken-ichi Fukuda   +2 more
doaj   +1 more source

Differential alteration of fMRI signal variability in the ascending trigeminal somatosensory and pain modulatory pathways in migraine

The Journal of Headache and Pain, 2021
Background The moment-to-moment variability of resting-state brain activity has been suggested to play an active role in chronic pain. Here, we investigated the regional blood-oxygen-level-dependent signal variability (BOLDSV) and inter-regional dynamic ...
Manyoel Lim, Hassan Jassar, Dajung J. Kim, Thiago D. Nascimento, Alexandre F. DaSilva   +4 more
doaj   +1 more source